What is Arformoterol tartrate?

Category: Prescription Drugs

Most popular types: Brovana

false

Arformoterol tartrate is administered in a nebulizer and used for long-term maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 1
Moderate 0
Mild 0
None 3

Commonly reported side effects and conditions associated with Arformoterol tartrate

Side effect Patients
Candida (fungal) infection 1

Dosages

Based on patients currently taking Arformoterol tartrate

Dosage Patients
7.5 mcg twice daily 1
15 mcg twice daily 1

Why patients stopped taking Arformoterol tartrate

Multiple reasons could be selected

Reason Patients
Side effects too severe 2
Change in health plan coverage 1
Did not seem to work 1
Doctor's advice 1
Other 1
See all 5 patients who've stopped taking Arformoterol tartrate

Duration

Currently taking Arformoterol tartrate

Duration Patients
Less than 1 month 1
1 - 6 months 1

Stopped taking Arformoterol tartrate

Duration Patients
Less than 1 month 2
1 - 6 months 3
Adherence
Adherence Evaluations
Always 1
Usually 2
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 2
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 2
< $25 0
Not specified 2

What people switch to and from

Patients started taking Arformoterol tartrate after stopping:

Treatment Patients
Budesonide-Formoterol (Symbicort) 1
Fluticasone-Salmeterol (Advair Diskus) 1
Last updated:

1 patient evaluation for Arformoterol tartrate

Aug 10, 2010 (Started Mar 15, 2010)

  • Effectiveness
    Slight (for shortness of breath (dyspnea))
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    Somewhat hard to take
Dosage: 2 x 15 mcg/2 mL Daily
Cost: $25-49 monthly

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for Arformoterol tartrate